Sorbitol

HCID 5780CAS 50-70-4

Basic information

Standard SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO
InChIKey
FBPFZTCFMRRESA-JGWLITMVSA-N
Molecular formula
C6H14O6
Average molar mass
182.17 g/mol
Monoisotopic mass
182.07903817

Overview

Sorbitol is an odorless colorless solid. Sinks and mixes with water. (USCG, 1999)

Names & identifiers

Preferred name
Sorbitol
IUPAC
(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol
English name
D-Sorbitol
Molecular formula
C6H14O6
Molecular weight
182.17

Names & synonyms

D-SorbitolsorbitolD-Glucitol50-70-4glucitolGlucarine(-)-SorbitolNivitinD-(-)-SorbitolDiakarmonSorbilandeSorbostyl
Show more names
Ai3-19424Ccris 1898Sorbitol impuritiesD-1,2,3,4,5,6-Hexanehexol(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol
EsasorbMultitolNeosorbSorboSorbolCholaxineSionitSionite

Database identifiers

CAS
50-70-4、69-65-8、98201-93-5
PubChem CID
5780
DTXSID
DTXSID5023588
ChEMBL
CHEMBL1682
ChEBI
CHEBI:17924
UNII
506T60A25R
EC Number
200-061-5、619-324-4
Nikkaji
J2.299C

Properties

Computed structural properties

XLogP
-3.1
Topological polar surface area
121 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
6
Rotatable bonds
5
Heavy atoms
12

Experimental & physicochemical properties

Chemical ClassesBiological Agents -> Monosaccharides and Derivatives
Drugs · 3 items

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals -> Metabolite of Isosorbide Dinitrate

Pharmaceuticals -> Listed in ZINC15

Cosmetics · 2 items

Cosmetic ingredients (Sorbitol) -> CIR (Cosmetic Ingredient Review)

Plasticiser; Skin conditioning; Humectant

pHpH: about 7.0
SpringerMaterials PropertiesCrystal structure
FragrancesFragrance Ingredient (d-Sorbitol) -> IFRA transparency List

Physicochemical properties

Melting point
97 · 97 - 100°C
storage temp.
Hygroscopic, Room Temperature, under inert atmosphere
solubility
DMSO (Sparingly), Water (Slightly)
form
Solid
pka
1 · pK1:13.60 (17.5°C)
color
White to Off-White

Safety & regulation

GHS classification

GHS Classification · 3 items

This chemical does not meet GHS hazard criteria for 100% (1338 of 1338) of all reports.

Not Classified

Aggregated GHS information provided per 1338 reports by companies from 2 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information · 4 items

Chemical: D-Glucitol

Regulation (EC) No 178/2002 (amended)

D-Glucitol is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of D-Glucitol are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

D-Glucitol: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - D-Glucitol: Environment tier I assessment
Fire HazardsCombustible. Finely dispersed particles form explosive mixtures in air.
Fire PotentialCombustible
Health HazardsHot liquid will burn skin. (USCG, 1999)
Hazards Summary · 1 item

No adverse effects on reproduction, development, or lactation observed in 3-generation study of rats at doses up to 10% of the diet; [REPROTOX] May cause gastrointestinal tract effects; Health effects of exposure to the substance have been investigated extensively but none have been found. [ICSC] May cause irritation; [Alfa Aesar MSDS] See Mannitol.

Safety & protection

Fire Fighting · 2 items

Fire Extinguishing Agents: Water (USCG, 1999)

In case of fire in the surroundings, use appropriate extinguishing media.

First AidOnly for burns caused by hot liquid. (USCG, 1999)
Fire Fighting Procedures · 3 items

In case of fire in the surroundings: use appropriate extinguishing media.

Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

Special protective equipment for fire-fighters: Wear self contained breathing apparatus for fire fighting if necessary.

Storage Conditions · 2 items

The bulk material is hygroscopic and should be stored in an airtight container in a cool, dry place.

Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Cleanup Methods · 3 items

Personal precautions: Avoid dust formation.

Environmental precautions: Do not let product enter drains.

Methods for cleaning up: Sweep up and shovel. Keep in suitable, closed containers for disposal.

Disposal Methods · 2 items

SRP: Criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Observe all federal, state, and local environmental regulations.

Toxicology

Interactions · 1 item

PURPOSE: To examine the effect of common excipients such as sugars (sorbitol versus sucrose) on bioequivalence between pharmaceutical formulations, using ranitidine and metoprolol as model drugs. METHODS: Two single-dose, replicated, crossover studies were first conducted in healthy volunteers (N=20 each) to compare the effect of 5 Gm of sorbitol and sucrose on bioequivalence of 150 mg ranitidine or 50 mg metoprolol in aqueous solution, followed by a single-dose, nonreplicated, crossover study (N=24) to determine the threshold of sorbitol effect on bioequivalence of 150 mg ranitidine in solution. RESULTS: Ranitidine Cmax and AUC0-infinity were decreased by approximately 50% and 45%, respectively, in the presence of sorbitol versus sucrose. Similarly, sorbitol reduced metoprolol Cmax by 23% but had no significant effect on AUC0-infinity. An appreciable subject-by-formulation interaction was found for ranitidine Cmax and AUC0-infinity, as well as metoprolol Cmax. Sorbitol decreased the systemic exposure of ranitidine in a dose-dependent manner and affected bioequivalence at a level of 1.25 Gm or greater. CONCLUSIONS: As exemplified by sorbitol, some common excipients have unexpected effect on bioavailability/bioequivalence, depending on the pharmacokinetic characteristics of the drug, as well as the type and amount of the excipient present in the formulation. More research is warranted to examine other common excipients that may have unintended influence on bioavailability/bioequivalence.

Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that D-sorbitol is expected to have very high mobility in soil(SRC). Volatilization of D-sorbitol from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 7.3X10-13 atm-cu m/mole(SRC), using a fragment constant estimation method(3). D-Sorbitol is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 9.9X10-9 mm Hg(SRC), determined from a fragment constant method(4). Utilizing the Japanese MITI test, 81% of the Theoretical BOD was reached in 2 weeks indicating(5) that biodegradation is an important environmental fate process in soil(SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that D-sorbitol is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 7.3X10-13 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). According to a classification scheme(5), an estimated BCF of 3(SRC), from its log Kow of -2.20(6) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). D-Sorbitol is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(3). Utilizing the Japanese MITI test, 81% of the Theoretical BOD was reached in 2 weeks(8) indicating that biodegradation is an important environmental fate process in water(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), D-sorbitol, which has an estimated vapor pressure of 9.9X10-9 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase D-sorbitol may be removed from the air by wet or dry deposition(SRC). D-Sorbitol does not contain chromophores that absorb at wavelengths >290 nm(3) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org
Plant ConcentrationsD-Sorbitol occurs naturally in apples, plums, pears, cherries, dates, peaches, apricots and other fruits(1).
Signs and SymptomsAbdominal cramps. Abdominal pain. Diarrhoea.
Soil Adsorption/Mobility · 1 item

Using a structure estimation method based on molecular connectivity indices(1), the Koc of D-sorbitol can be estimated to be 10(SRC). According to a classification scheme(2), this estimated Koc value suggests that sorbitol is expected to have very high mobility in soil.

Regulatory information

FDA Requirements · 5 items

Substance added directly to human food affirmed as generally recognized as safe (GRAS).

Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. A number of active ingredients have been present in OTC drug products for various uses, as described below. However, based on evidence currently available, there are inadequate data to establish general recognition of the safety and effectiveness of these ingredients for the specified uses: sorbitol is included in digestive aid drug products.

Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. A number of active ingredients have been present in OTC drug products for various uses, as described below. However, based on evidence currently available, there are inadequate data to establish general recognition of the safety and effectiveness of these ingredients for the specified uses: sorbitol is included in oral health care drug products (nonantimicrobial).

Sorbitol used as a nutrient and/or dietary supplement in animal drugs, feeds, and related products is generally recognized as safe when used in accordance with good manufacturing or feeding practice.

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl sorbitol, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.

FIFRA Requirements · 1 item

Unless specifically excluded, residues resulting from the use of the following substances as either an inert or an active ingredient in a pesticide chemical formulation, including antimicrobial pesticide chemicals, are exempted from the requirement of a tolerance under FFDCA section 408, if such use is in accordance with good agricultural or manufacturing practices. D-Sorbitol is included on this list.

Chemistry & industry

Pharmacology

ATC Code · 6 items

A06AD18

A - Alimentary tract and metabolism

B - Blood and blood forming organs

V - Various

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Mechanism of Action · 5 items

Sorbitol exerts its laxative effect by drawing water into the large intestine, thereby stimulating bowel movements.

... Sorbitol exerts hygroscopic and/or local irritant action, drawing water from tissues into feces and reflexly stimulating evacuation.

The polyol pathway consists of two enzymes aldose reductase (AR) and sorbitol dehydrogenase (SDH); the former is the first enzyme in the polyol pathway, that catalyzes the reduction of glucose to sorbitol, the latter is the second one, that converts sorbitol to fructose using by NAD(+) as a cofactor. ... SDH activity, the second step in the polyol pathway, might make a greater contribution to the etiology of diabetic retinopathy than does the first step involving AR. /This paper proposes/ a novel hypothesis that polymorphisms of SDH gene may be correlated with SDH gene expression levels in diabetic retinas, thus being a valuable genetic marker for diabetic retinopathy.

It has been reported that sorbitol induces apoptosis in several cancer cell lines. ... In /this/ study, the intracellular signaling pathways of sorbitol-induced apoptosis in human K562 cells were investigated using both morphological analysis and DNA fragmentation technique. In this study, we demonstrated that sorbitol-induced apoptosis in human K562 cells is a concentration- and time-dependent manner. This sorbitol-induced apoptosis in human K562 cells was also accompanied by the up-regulation of Bax, and down-regulation of p-Bcl-2, but no effect on the levels of Bcl-X(L). Moreover, the sorbitol treatment resulted in a significant reduction of mitochondria membrane potential, increase in the release of mitochondrial cytochrome c (cyt c), and activation of caspase 3. Furthermore, treatment with caspase 3 inhibitor (z-DEVD-fmk) was capable of preventing the sorbitol-induced caspase 3 activity and cell death. These results clearly demonstrate that the induction of apoptosis by sorbitol involves multiple cellular/molecular pathways and strongly suggest that pro- and anti-apoptotic Bcl-2 family proteins, mitochondrial membrane potential, mitochondrial cyt c, and caspase 3, they all participate in sorbitol-induced apoptotic process in human K562 cells.

Chronic diabetic complications, in particular, nephropathy, peripheral and autonomic neuropathy, "diabetic foot," retinopathy, and cardiovascular disease, remain the major cause of morbidity and mortality in patients with diabetes mellitus. Growing evidence indicates that both increased activity of the sorbitol pathway of glucose metabolism and enhanced oxidative stress are the leading factors in the pathogenesis of diabetic complications. The relation between the two mechanisms remains the area of controversy. One group has reported that increased sorbitol pathway activity has a protective rather than detrimental role in complication-prone tissues because the pathway detoxifies toxic lipid peroxidation products. Others put forward a so-called "unifying hypothesis" suggesting that activation of several major pathways implicated in diabetic complications (eg, sorbitol pathway) occurs due to increased production of superoxide anion radicals in mitochondria and resulting poly(ADP-ribose) polymerase activation. This review (a) presents findings supporting a key role for the sorbitol pathway in oxidative stress and oxidative stress-initiated downstream mechanisms of diabetic complications, and (b) summarizes experimental evidence against a detoxifying role of the sorbitol pathway, as well as the "unifying concept."

Metabolism/Metabolites · 2 items

Sorbitol is widely used in a number of pharmaceutical products and occurs naturally in many edible fruits and berries. It is absorbed more slowly from the gastrointestinal tract than sucrose and is metabolized in the liver to fructose and glucose ... Sorbitol is better tolerated by diabetics than sucrose and is widely used in many sugar-free liquid vehicles ...

70% of orally ingested sorbitol is converted to carbon dioxide without appearing as glucose in the blood ...

MeSH Pharmacological Classification · 3 items

Agents that are used to stimulate evacuation of the bowels.

Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499)

Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed)

Absorption, Distribution and Excretion · 6 items

Sorbitol will either be excreted in the urine by the kidneys, or metabolized to carbon dioxide and dextrose.

The amounts of sorbitol (SOR) excreted in 24-hr urine were determined on two groups, ie, diabetic and nondiabetic patients, using an improved method in which ion exchange resin column processing was applied, and these levels were compared with SOR levels in whole blood. Urinary SOR concentration was also determined in diabetic and normal rats in the same manner and its relationship to aldose reductase (AR) activity in whole blood was investigated. Changes in SOR levels in urine and whole blood were compared in diabetic rats after administration of an AR inhibitor (ARI). Whole blood SOR levels and urinary SOR excretion were significantly higher in diabetic patients than in nondiabetic patients. The same results were obtained in the animal models. In diabetic rats, the urinary SOR excretion was about five times higher than that in control rats, and the AR activity in whole blood was also significantly higher. The increase in urinary SOR excretion and whole blood SOR levels, as well as AR activity, in blood in the diabetic state was inhibited by ARI administration. The influence of the diabetic state and the efficacy of the ARI were more marked in urinary SOR excretion than in whole blood SOR levels. These data indicate that determinations of urinary SOR excretion and AR activity are easily measurable and of benefit to assessing the diabetic condition.

An accelerated polyol pathway in diabetes contributes to the development of diabetic complications. To elucidate diabetic nephropathy involving also renal tubular damage, ...urinary sorbitol concentrations /were measured/ concomitantly with urinary N-acetyl-D-glucosaminidase (NAG) excretion in WBN-kob diabetic rats.Twenty-four-hour urinary sorbitol concentrations increased in the diabetic rats in parallel with whole blood sorbitol concentrations. An increase in 24-h urinary NAG excretion coincided with the elevated urinary sorbitol levels in the diabetic rats. The administration of epalrestat, an aldose reductase inhibitor, reduced the increased whole blood and urinary sorbitol concentrations and urinary NAG excretion concomitantly with renal aldose reductase inhibition in the diabetic rats. These results indicate that diabetic nephropathy involves distorted cell function of renal tubules, and that treatment with epalrestat may prevent at least the progress of the nephropathy.

The purpose of this study was to determine whether sorbitol concentration is elevated in the cerebrospinal fluid (CSF) of non-medically ill patients with mood disorders. Lumbar punctures were performed on 30 subjects - 10 with bipolar mood disorder, 10 with unipolar mood disorder, and 10 age-matched normal controls, and CSF sorbitol concentrations were measured, using a gas chromatographic-mass spectroscopic technique. The mean+/-standard deviation of CSF sorbitol concentrations differed among the three groups as follows: bipolar (22.9+/-4.6 umoles/L) > unipolar (19.0+/-2.8 umoles/L)>normal control (15. 6+/-1.9 umoles/L). One-way ANOVA showed significant (P=0.0002) differences among the three groups. Post-hoc tests indicated a significant (P<0.05) difference between bipolars and normal controls, bipolars and unipolars, and unipolars and normal controls...

Streptozocin (Str) diabetic rats were obtained by Str iv (35 mg/kg). Glycemia and sorbitol levels from sciatic nerve and lens were measured after 1 d, 2, 5, and 8 months of diabetes. Sorbitol concentrations in serum, heart, diaphragm, small intestine, and kidney after 8 months of diabetes were measured. RESULTS: Diabetic rats after Str injection showed hyperglycemia (> 1.7 g.L-1), hyperphagia, polyuria, polydipsia, and loss of body weight. Sorbitol levels in lens and sciatic nerve increased in normal and diabetic rats; the increase was higher in diabetic rats. No relationship was shown between glycemia and sorbitol levels. An increased sorbitol level after 8 months of diabetes was found in small intestine and kidney...

For more Absorption, Distribution and Excretion (Complete) data for D-Sorbitol (8 total), please visit the HSDB record page.

Tissue LocationsAdipose Tissue

Uses & manufacturing

Uses · 6 items

CIR ingredient: Sorbitol

Found in many fruits, seaweed, and algae; Used to make sorbose, ascorbic acid, propylene glycol, synthetic plasticizers, and resins; Used as a moisture conditioner on printing rolls, leather, tobacco, writing inks, antifreeze mixtures, and food and beverage manufacturing; Also used as a sugar substitute for diabetics, pharmaceutic aid, and laxative; [Merck Index] Used in cosmetics, as a plasticizer in film formulations, surfactant, in urethane resins and rigid foams, as stabilizer for vinyl resins, in varnishes and lacquers, as a sequestrant for some multivalent metals, and for various other food, pharmaceutical, and medical applications; [HSDB] Used as a flavoring agent, color, nutritional supplement, pH control agent, drying agent, humectant, solvent, texturizer, and stabilizer or thickener for foods; [FDA] Permitted for use as an inert ingredient in non-food pesticide products; [EPA]

Painting (Pigments, Binders, and Biocides) [Category: Paint]

Sorbitol is widely used as an excipient in pharmaceutical formulations. It is also used extensively in cosmetics and food products. Sorbitol is used as a diluent in tablet formulations prepared by either wet granulation or direct compression. It is particularly useful in chewable tablets owing to its pleasant, sweet taste and cooling sensation. In capsule formulations it is used as a plasticizer for gelatin. Sorbitol has been used as a plasticizer in film formulations. In liquid preparations sorbitol is used as a vehicle in sugar-free formulations and as a stabilizer for drug, vitamin, and antacid suspensions. Furthermore, sorbitol is used as an excipient in liquid parenteral biologic formulations to provide effective protein stabilization in the liquid state. It has also been shown to be a suitable carrier to enhance the in vitro dissolution rate of indometacin. In syrups it is effective in preventing crystallization around the cap of bottles. Sorbitol is additionally used in injectable and topical preparations ... Sorbitol may also be used analytically as a marker for assessing liver blood flow.

In the manufacture of sorbose, ascorbic acid, propylene glycol, synthetic plasticizers and resins; as humectant (moisture conditioner) on printing rolls; in leather; in writing inks; in candy mfr; in antifreeze mixture with glycerol or glycols increases absorption of pharmaceutical preparation; pharmaceutic aid (sweetening agent; tablet excipient); sugar substitute for diabetics.

Food uses of polyhydric alcohol, /sorbitol is used in flavor concentrate; confections; chewing gum; dried roasted nuts; meat products; pet foods; icings and toppings; coconut; beverages; special dietary foods/.

Impurities · 1 item

Arsenic (as As): not more than 3 mg/kg; Chloride: not more than 0.005%; Heavy metals (as Pb): not more than 5 mg/kg; Lead: not more than 1 mg/kg; reducing sugar: Not more than 0.3%; Ash: not more than 0.1%; Sulfate: not more than 0.01%; Total sugars: not more than 1.0%; Water: not more than 1.0%

U.S. Exports · 5 items

(1984) 6.6 1X 10+9 g

CHEMICAL PROFILE: Sorbitol. US Exports: 1991: 25.2 million pounds.

CHEMICAL PROFILE: Sorbitol. US Exports: 1994: 40 million pounds.

CHEMICAL PROFILE: Sorbitol. US Exports: 1999: 53 million pounds; 2000: 53 million pounds.

For more U.S. Exports (Complete) data for D-Sorbitol (7 total), please visit the HSDB record page.

U.S. Imports · 5 items

(1975) 2.87 X 10+9 g

(1984) 8.17 X 10+9 g /70% basis/

CHEMICAL PROFILE: Sorbitol. US Imports: 1989: 20 million pounds.

CHEMICAL PROFILE: Sorbitol. US Imports: 1991: 20.7 million pounds.

For more U.S. Imports (Complete) data for D-Sorbitol (8 total), please visit the HSDB record page.

U.S. Production · 6 items

2023: 55,000,000 - <70,000,000 lb

(1972) 6.31 X 10+10 g

(1975) 6.07 X 10+10 g

(1984) 8.68 X 10+10 g /70% by wt/

(1993) 1.40566 X 10+8 kg

For more U.S. Production (Complete) data for D-Sorbitol (15 total), please visit the HSDB record page.

Consumption Patterns · 5 items

24% as a chemical intermediate for Vitamin C; 24% as a humectant in tooth paste and as a gel base for pharmaceuticals; 16% as a humectant and sugarless additive to foods; 15% as a chemical intermediate for industrial surfactants, derivatives used in cosmetics and foods, and dispersants and stabilizers in pharmaceuticals; 7% as a liquid vehicle, stabilizer, and sweetener in pharmaceuticals; 2% as a chemical intermediate for polyethers; 12% in miscellaneous applications, including as a substitute for glycerin, chemical intermediate for glycerin substitutes, and a humectant in tobacco, paste polishes, and pet foods (1974)

Toothpaste, 35%; Foods, Candy & confections, 30%; Ascorbic acid & salts, 20%; Surfactants, 5%; Cosmetics & toiletries, 3%; Pharmaceuticals, 2%; Miscellaneous, 5% (1984)

CHEMICAL PROFILE: Sorbitol. US End-use Pattern for Sorbitol in 1986.

CHEMICAL PROFILE: Sorbitol. US End-use Pattern for Sorbitol in 1989.

For more Consumption Patterns (Complete) data for D-Sorbitol (18 total), please visit the HSDB record page.

Applications

UsesD-Sorbitol is a sugar alcohol that is naturally found in Toyon berries. D-Sorbitol is used to increase stability of silver nanoparticles and is also used as a sugar substitute.

Suppliers50 total

Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
山东泰诚生物科技有限公司18769832557 18769832557 · [email protected]
河南赢创生物科技有限公司16650615803 · [email protected]
湖北云镁科技有限公司027-59206672 18995657604 · [email protected]
江西瑞威尔生物科技有限公司18502728206 · [email protected]

Related reactions

188 records

Linked notes

Loading…